Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
Artificial Intelligence, COVID-19, and the Future of Pandemics
Artificial intelligence (AI) has proven of value in the COVID-19 pandemic and shows promise for mitigating future healthcare crises.
Shoulder Dystocia Documentation: Implementing a Protocol
Shoulder dystocia claims have traditionally been among the most problematic to defend.
AM Best Revises Outlooks to Positive for The Doctors Company and Subsidiaries
AM Best has revised the outlooks to positive from stable and affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and the long-term issuer credit rating (ICR) of "a+”. The positive outlooks, FSR of A, and long-term ICR of “a+” have been affirmed for The Doctors Company, an Interinsurance Exchange, and its core subsidiaries, which collectively comprise The Doctors Company Insurance Group (TDC or TDC Group).
Mar 07, 2023
In Memoriam: Donald J. Palmisano, MD, JD, FACS
It is with great sadness that we report the passing of long-time Board Member Donald J. Palmisano, MD, JD, FACS.
From
The Doctor’s Advocate
The Importance of Clinical Health Information at the Point of Radiology Order
Having ready access to patients’ clinical information helps radiologists eliminate assumptions and apply their skills and expertise in rendering accurate interpretive reports.
June 10, 2024, The Podcast by KevinMD
AI, the Physician Shortage, and Other Healthcare Trends
Richard E. Anderson, MD, FACP, Chairman and Chief Executive Officer of The Doctors Company and TDC Group, discusses issues shaping the future of U.S. healthcare, from the impact of AI-powered clinical decision support tools to strategies for addressing physician shortages and managing healthcare costs amid consolidation.
February 06, 2024
TDC Group Appoints Daniel Kent Cassavar, MD, MBA, as Medical Director
TDC Group announced today the appointment of Daniel Kent Cassavar, MD, MBA, as Medical Director. Dr. Cassavar is a member of The Doctors Company’s Board of Governors, is a practicing cardiologist, and has held significant leadership roles in healthcare.
Sep 05, 2025
Record Tribute Plan Milestone: Over $200 Million Distributed to Members
The Doctors Company has now distributed more than $200 million in Tribute® Plan awards to over 15,000 members, and other industry and company news.
From
The Doctor’s Advocate
MPL Case: Could Closing the Loop Have Saved This Patient's Life?
Confirming a colleague’s receipt and understanding of serious findings is part of patient safety. Further, closed-loop communication expresses mutual respect, which contributes to professional satisfaction.
